FDA determined that marketing claims surrounding product rendered product a medical device which was adulterated and misbranded.
Source facts
Action
The firm initiated the recall on 09/23/2019 by email and followed with a second letter on 10/18/2019. The letter requests the consignee discard/destroy the product.
Initiated
2019-10-18
Root cause
No Marketing Application
Distribution
US, Puerto Rico, U.S. Virgin Islands, Canada, Mexico, Australia, PHILIPPINES, Greece, United Kingdom, Israel, Nigeria, Hungary, United Arab Emirates
Recall number
Z-0348-2020
Recall status
Completed
CDRH record ID
177227
FDA record created
2019-11-08
Recall event number
84117
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.